Back to top
more

CVS Health (CVS)

(Real Time Quote from BATS)

$54.96 USD

54.96
2,638,641

-1.98 (-3.48%)

Updated Sep 11, 2024 11:10 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (234 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

CVS Health (CVS) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

CVS Health (CVS) delivered earnings and revenue surprises of 1.17% and 0.17%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Benjamin Rains headshot

What to Expect from CVS Health's Q3 Earnings

by Benjamin Rains

Let's see what to expect from CVS before the opening bell Tuesday.

Benjamin Rains headshot

Should You Buy CVS Stock Ahead of Q3 Earnings?

by Benjamin Rains

Let's see if investors should think about buying CVS stock ahead of its Q3 financial results.

Ryan McQueeney headshot

Upcoming Earnings Reports to Watch: CVS, QCOM, DIS

by Ryan McQueeney

Stocks were down in morning trading Friday, putting major indexes on track to snap a three-day winning streak that followed a brutal month of selling. But will next week's earnings results get the rebound back on track? Let's take a closer look at a few of the earnings announcements due during the week of November 5!

CVS Health (CVS) Gains But Lags Market: What You Should Know

by Zacks Equity Research

CVS Health (CVS) closed the most recent trading day at $72.84, moving +0.61% from the previous trading session.

Will CVS Health's (CVS) PBM Strength Boost Q3 Earnings?

by Zacks Equity Research

Despite a challenging pricing scenario, CVS Health (CVS) is currently gaining on high level of service and execution as well as a competitive pricing along with unique integrated model.

Aetna (AET) Q3 Earnings Beat Estimates, Membership Increases

by Zacks Equity Research

Aetna (AET) earnings grow on revenue and membership gains.

CVS Health (CVS) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CVS Health (CVS) Gains But Lags Market: What You Should Know

by Zacks Equity Research

CVS Health (CVS) closed the most recent trading day at $70.67, moving +1.23% from the previous trading session.

CVS Health (CVS) Gains But Lags Market: What You Should Know

by Zacks Equity Research

CVS Health (CVS) closed at $73.72 in the latest trading session, marking a +0.9% move from the prior day.

Benjamin Rains headshot

Walgreens Boots (WBA) Stock Looks Like A Cheap, Solid Buy Right Now

by Benjamin Rains

Shares of Walgreens Boots Alliance (WBA) jumped roughly 1.6% Monday as investors continue to dive in after it posted impressive fiscal fourth-quarter results late last week. Looking ahead, the pharmaceutical giant looks poised for strong growth and WBA stock seems like it might be worth buying right now.

Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CVS Health (CVS) Stock Moves -0.72%: What You Should Know

by Zacks Equity Research

In the latest trading session, CVS Health (CVS) closed at $78.92, marking a -0.72% move from the previous day.

Benjamin Rains headshot

Walgreens (WBA) Stock Sinks 1.7% Ahead of Q4 Earnings: What to Watch

by Benjamin Rains

Shares of Walgreens Boots Alliance (WBA) slipped 1.7% during regular trading hours Wednesday in a sign that investors might be a tad bit nervous about the pharmacy and cosmetic giant's Q4 earnings results Thursday.

The Zacks Analyst Blog Highlights: JPMorgan, American Express, FedEx, PepsiCo and CVS

by Zacks Equity Research

The Zacks Analyst Blog Highlights: JPMorgan, American Express, FedEx, PepsiCo and CVS

Mark Vickery headshot

Top Research Reports for JPMorgan, American Express & FedEx

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan (JPM), American Express (AXP) and FedEx (FDX).

Sweta Killa headshot

Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Hot ETF Right Now?

by Sweta Killa

Smart Beta ETF report for FLQL

CVS Health's Aetna Deal Imminent, PBM Selling Season Strong

by Zacks Equity Research

CVS Health (CVS) is steadily approaching the Aetna deal wrap-up. Per the company, this significant buyout might alter the whole Healthcare landscape in the United States.

The Zacks Analyst Blog Highlights: Adobe, United Technologies, Lockheed Martin, CVS Health and Coca-Cola

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Adobe, United Technologies, Lockheed Martin, CVS Health and Coca-Cola

    Benjamin Rains headshot

    Should You Buy Walgreens Boots (WBA) Stock Ahead of Q4 Earnings?

    by Benjamin Rains

    Walgreens Boots Alliance (WBA) shares have surged 17% in the last three months to outpace the S&P 500's roughly 7% climb as fears that Amazon's (AMZN) pharmaceutical push would doom the pharmacy giant prove overblown. Now the question is should investors consider buying WBA stock ahead of its Q4 earnings release on October 11?

      Mark Vickery headshot

      Top Research Reports for Adobe, United Technologies & Lockheed Martin

      by Mark Vickery

      Today's Research Daily features new research reports on 16 major stocks, including Adobe (ADBE), United Technologies (UTX) and Lockheed Martin (LMT).

        Here's Why You Should Invest in CVS Health (CVS) Stock Now

        by Zacks Equity Research

        CVS Health's (CVS) solid cash position is encouraging. Strong 2019 PBM selling season is another upside.

          Is CVS Health (CVS) Stock Undervalued Right Now?

          by Zacks Equity Research

          Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

            Cigna Gets Merger Nod, Forms Management for Unified Entity

            by Zacks Equity Research

            Cigna (CI) forms management as it prepares for new merged entity.

              WellCare Health's (WCG) Buyout to Expand Medicare Business

              by Zacks Equity Research

              WellCare Health's (WCG) impending buyout of Aetna's Medicare business to expand and cement its foothold in the rapidly growing market.